Sign inGet started

Lehrer-Graiwer Joshua

Insider CIK 1789673 · GBT Chief Medical Officer · FULC Director · GRPH PRESIDENT AND CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
FULC Fulcrum Therapeutics, Inc. A Award deriv2026-04-232026-05-0164,000— $064,000SEC↗
GRPH Graphite Bio, Inc. A Award deriv2023-02-212023-02-23600,000— $0600,000SEC↗
GRPH Graphite Bio, Inc. A Award deriv2022-02-162022-02-18650,000— $0650,000SEC↗
GRPH Graphite Bio, Inc. C Conversion deriv2021-06-292021-07-0119,763— $00SEC↗
GRPH Graphite Bio, Inc. C Conversion2021-06-292021-07-018,126— $01,161,670SEC↗
GRPH Graphite Bio, Inc. A Award deriv2021-03-172021-07-01795,196— $0795,196SEC↗
GRPH Graphite Bio, Inc. A Award deriv2021-03-172021-07-01340,798— $0340,798SEC↗
GRPH Graphite Bio, Inc. A Award deriv2021-03-112021-07-0119,763$5.06 $100.0K19,763SEC↗
GRPH Graphite Bio, Inc. M Exercise deriv2021-01-162021-07-01374,013— $00SEC↗
GRPH Graphite Bio, Inc. M Exercise2021-01-162021-07-01374,013$0.30 $112.2K1,153,544SEC↗
GRPH Graphite Bio, Inc. A Award deriv2021-01-132021-07-01374,013— $0374,013SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-03-092020-03-09938— $01,875SEC↗
GBT Global Blood Therapeutics, M Exercise2020-03-092020-03-09938$19.89 $18.7K3,533SEC↗
GBT Global Blood Therapeutics, S Sale2020-03-092020-03-09938$59.90 $56.2K2,595SEC↗
GBT Global Blood Therapeutics, S Sale2020-03-052020-03-091,138$65.30 $74.3K2,595SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-03-012020-03-041,750— $03,500SEC↗
GBT Global Blood Therapeutics, F Tax w/h2020-03-012020-03-04612$63.96 $39.1K3,733SEC↗
GBT Global Blood Therapeutics, M Exercise2020-03-012020-03-041,750— $04,345SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-02-182020-02-201,313— $05,250SEC↗
GBT Global Blood Therapeutics, M Exercise2020-02-182020-02-201,313$26.90 $35.3K3,908SEC↗
GBT Global Blood Therapeutics, S Sale2020-02-182020-02-201,313$69.71 $91.5K2,595SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-02-102020-02-10625— $00SEC↗
GBT Global Blood Therapeutics, M Exercise2020-02-102020-02-10625$12.95 $8.1K3,220SEC↗
GBT Global Blood Therapeutics, S Sale2020-02-102020-02-10625$70.48 $44.0K2,595SEC↗
GBT Global Blood Therapeutics, S Sale2020-02-062020-02-103,937$72.40 $285.0K2,595SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-02-032020-02-041,657— $013,250SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-02-032020-02-042,188— $026,250SEC↗
GBT Global Blood Therapeutics, A Award deriv2020-02-032020-02-0438,500— $038,500SEC↗
GBT Global Blood Therapeutics, A Award deriv2020-02-032020-02-0424,160— $024,160SEC↗
GBT Global Blood Therapeutics, S Sale2020-02-032020-02-041,657$65.00 $107.7K6,532SEC↗
GBT Global Blood Therapeutics, M Exercise2020-02-032020-02-042,188$48.44 $106.0K8,720SEC↗
GBT Global Blood Therapeutics, S Sale2020-02-032020-02-042,188$62.81 $137.4K6,532SEC↗
GBT Global Blood Therapeutics, M Exercise2020-02-032020-02-041,657$59.60 $98.8K8,189SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-02-012020-02-041,037— $03,113SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-02-012020-02-042,125— $08,500SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-02-012020-02-042,938— $017,625SEC↗
GBT Global Blood Therapeutics, M Exercise2020-02-012020-02-046,100— $08,695SEC↗
GBT Global Blood Therapeutics, F Tax w/h2020-02-012020-02-042,163$65.26 $141.2K6,532SEC↗
GBT Global Blood Therapeutics, A Award2020-01-312020-02-04579$36.68 $21.2K2,595SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-01-272020-01-29781— $04,688SEC↗
GBT Global Blood Therapeutics, M Exercise2020-01-272020-01-29781$27.90 $21.8K2,797SEC↗
GBT Global Blood Therapeutics, S Sale2020-01-272020-01-29781$71.15 $55.6K2,016SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-12-132019-12-174,000— $00SEC↗
GBT Global Blood Therapeutics, F Tax w/h2019-12-132019-12-171,984$76.88 $152.5K2,016SEC↗
GBT Global Blood Therapeutics, M Exercise2019-12-132019-12-174,000— $04,000SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-12-092019-12-11937— $02,813SEC↗
GBT Global Blood Therapeutics, S Sale2019-12-092019-12-11937$78.50 $73.6K0SEC↗
GBT Global Blood Therapeutics, M Exercise2019-12-092019-12-11937$19.89 $18.6K937SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-262019-11-2711,593— $014,907SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-262019-11-2711,593$59.60 $690.9K11,593SEC↗
GBT Global Blood Therapeutics, S Sale2019-11-262019-11-2711,593$67.19 $778.9K0SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-252019-11-27312— $0625SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-252019-11-27656— $06,563SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-252019-11-273,515— $05,469SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-252019-11-27447— $00SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-252019-11-27298— $03,750SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-252019-11-274,594— $07,219SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-252019-11-271,108— $04,048SEC↗
GBT Global Blood Therapeutics, S Sale2019-11-252019-11-27312$60.00 $18.7K0SEC↗
GBT Global Blood Therapeutics, S Sale2019-11-252019-11-27656$60.00 $39.4K0SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-252019-11-27656$26.90 $17.6K656SEC↗
GBT Global Blood Therapeutics, S Sale2019-11-252019-11-274,594$60.00 $275.6K0SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-252019-11-274,594$26.90 $123.6K4,594SEC↗
GBT Global Blood Therapeutics, S Sale2019-11-252019-11-27298$60.00 $17.9K0SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-252019-11-27298$19.89 $5.9K298SEC↗
GBT Global Blood Therapeutics, S Sale2019-11-252019-11-27447$60.00 $26.8K0SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-252019-11-27447$20.00 $8.9K447SEC↗
GBT Global Blood Therapeutics, S Sale2019-11-252019-11-273,515$60.00 $210.9K0SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-252019-11-273,515$27.90 $98.1K3,515SEC↗
GBT Global Blood Therapeutics, S Sale2019-11-252019-11-271,108$60.00 $66.5K0SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-252019-11-271,108$19.89 $22.0K1,108SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-252019-11-27312$12.95 $4.0K312SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-192019-11-206,562— $028,438SEC↗
GBT Global Blood Therapeutics, S Sale2019-11-192019-11-206,562$55.00 $360.9K0SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-192019-11-206,562$48.44 $317.9K6,562SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-182019-11-20656— $011,813SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-182019-11-20656$26.90 $17.6K656SEC↗
GBT Global Blood Therapeutics, S Sale2019-11-182019-11-20656$50.63 $33.2K0SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-152019-11-18313— $0937SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-152019-11-181,109— $05,454SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-152019-11-18118— $0447SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-152019-11-18298— $05,156SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-152019-11-184,594— $012,469SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-152019-11-183,516— $08,984SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-152019-11-181,109$19.89 $22.1K1,422SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-152019-11-184,594$26.90 $123.6K9,948SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-152019-11-18298$19.89 $5.9K5,354SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-152019-11-18118$20.00 $2.4K5,056SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-152019-11-183,516$27.90 $98.1K4,938SEC↗
GBT Global Blood Therapeutics, S Sale2019-11-152019-11-189,948$50.00 $497.4K0SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-152019-11-18313$12.95 $4.1K313SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-11-142019-11-18329— $0565SEC↗
GBT Global Blood Therapeutics, M Exercise2019-11-142019-11-18329$20.00 $6.6K329SEC↗
GBT Global Blood Therapeutics, S Sale2019-11-142019-11-18329$50.01 $16.5K0SEC↗
GBT Global Blood Therapeutics, A Award deriv2019-10-012019-10-031,500— $01,500SEC↗
GBT Global Blood Therapeutics, A Award deriv2019-10-012019-10-035,000— $05,000SEC↗